Signature scores of immune checkpoints, including CTLA4, LAG3, PDCD1, PD-L1, PD-L2 and TIGIT as well as the top five marker genes within each TAM subset were calculated using RNA-seq data from TCGA low grade glioma patients. This evidence concerns the gene PDCD1LG2 and central nervous system cancer.